Cutaneous melanoma, the most aggressive form of skin cancer, is characterized by its accumulation of a large number of ...

A discovery published in Nature Immunology has shed light on why the immune system is less aggressive toward self-antigens, ...

This Phase 2 trial aims to assess the safety, tolerability, and foralumab’s effect on microglial activation in patients with na-SPMS. Intranasal foralumab offers a novel approach to potentially ...

The death of former U.S. Rep. Mia Love has brought renewed attention to an aggressive form of brain cancer that killed her at ...

Therefore, for safety reasons, the initial trials of immunotherapy with human ALS should be based on passive immunization approaches. Such passive immunization will require the use of a large ...

“The immunotherapy meant less chemotherapy, so I was less sick which was positive,” she said. Bianca Edwards got a second chance from the immunotherapy drug. Picture: Justin Lloyd. “It also ...

Enhertu is a combination of a chemotherapy drug and targeted therapy. This type of therapy differs from immunotherapy. Doctors prescribe Enhertu for certain types of breast, lung, and other ...

State Key Laboratory of Coordination Chemistry, School of Chemistry and Chemical Engineering, Chemistry and Biomedicine Innovation Center (ChemBIC), ChemBioMed Interdisciplinary Research Center, ...

A generation ago, a diagnosis of multiple sclerosis often meant a steady decline in quality of life. The autoimmune disease, which affects nearly a million people in the U.S., causes the immune ...

EM, AR, EG and AT performed coculture experiments. SA, RS and AL provided plasmids and advised on the murine models. VM, MS, SLF and JL collected the tissues and clinical data. BK performed scRNA-seq ...

When Rayan Daboul received her diagnosis of multiple sclerosis (MS) at just 22, her life was turned upside down. “I had no idea what MS was, and I went into denial, thinking I could just ...